LymphedemaV1, Main, Exploration, bibRecordById, pubmed:20665892

Lymphedema Beyond Breast Cancer: A Systematic Review and Meta-Analysis of Cancer-Related Secondary Lymphedema

Identifieur interne : 005E77 ( Main/Exploration ); précédent : 005E76; suivant : 005E78

Lymphedema Beyond Breast Cancer: A Systematic Review and Meta-Analysis of Cancer-Related Secondary Lymphedema

Auteurs : Janice N. Cormier [États-Unis] ; Robert L. Askew [États-Unis] ; Kristi S. Mungovan [États-Unis] ; YAN XING [États-Unis] ; Merrick I. Ross [États-Unis] ; Jane M. Armer [États-Unis]

Source :

Cancer [ 0008-543X ] ; 2010.

RBID : Pascal:11-0088040

Descripteurs français

KwdFr :
- Complications postopératoires, Contrôle de qualité, Facteurs de risque, Femelle, Humains, Lymphadénectomie, Lymphoedème (diagnostic), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Tumeurs (), Tumeurs du sein ().
MESH :
- diagnostic : Lymphoedème.
- épidémiologie : Lymphoedème.
- étiologie : Lymphoedème.
Pascal (Inist)
- Complications postopératoires, Contrôle de qualité, Facteurs de risque, Femelle, Humains, Lymphadénectomie, Lymphoedème, Revue bibliographique, Métaanalyse, Cancer du sein, Cancérologie, Second cancer, Tumeur maligne, Chirurgie, Traitement, Tumeurs, Tumeurs du sein.
Wicri :
- topic : Chirurgie.

English descriptors

KwdEn :
- Bibliographic review, Breast Neoplasms (complications), Breast Neoplasms (therapy), Breast cancer, Cancerology, Female, Humans, Lymph Node Excision, Lymphedema, Lymphedema (diagnosis), Lymphedema (epidemiology), Lymphedema (etiology), Malignant tumor, Metaanalysis, Neoplasms (complications), Postoperative Complications, Quality Control, Risk Factors, Second cancer, Surgery, Treatment.
MESH :
- complications : Breast Neoplasms, Neoplasms.
- diagnosis : Lymphedema.
- epidemiology : Lymphedema.
- etiology : Lymphedema.
- therapy : Breast Neoplasms.
- Female, Humans, Lymph Node Excision, Postoperative Complications, Quality Control, Risk Factors.

Abstract

BACKGROUND: Secondary lymphedema is a debilitating, chronic, progressive condition that commonly occurs after the treatment of breast cancer. The purpose of the current study was to perform a systematic review and meta-analysis of the oncology-related literature excluding breast cancer to derive estimates of lymphedema incidence and to identify potential risk factors among various malignancies. METHODS: The authors systematically reviewed 3 major medical indices (MEDLINE, Cochrane Library databases, and Scopus) to identify studies (1972-2008) that included a prospective assessment of lymphedema after cancer treatment. Studies were categorized according to malignancy, and data included treatment, complications, lymphedema measurement criteria, lymphedema incidence, and follow-up interval. A quality assessment of individual studies was performed using established criteria for systematic reviews. Bayesian meta-analytic techniques were applied to derive summary estimates when sufficient data were available. RESULTS: A total of 47 studies (7779 cancer survivors) met inclusion criteria: melanoma (n = 15), gynecologic malignancies (n = 22), genitourinary cancers (n = 8), head/neck cancers (n = 1), and sarcomas (n = 1). The overall incidence of lymphedema was 15.5% and varied by malignancy (P < .001): melanoma, 16% (upper extremity, 5%; lower extremity, 28%); gynecologic, 20%; genitourinary, 10%; head/neck, 4%; and sarcoma, 30%. Increased lymphedema risk was also noted for patients undergoing pelvic dissections (22%) and radiation therapy (31%). Objective measurement methods and longer follow-up were both associated with increased lymphedema incidence. CONCLUSIONS: Lymphedema is a common condition affecting cancer survivors with various malignancies. The incidence of lymphedema is related to the type and extent of treatment, anatomic location, heterogeneity of assessment methods, and length of follow-up.

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Lymphedema Beyond Breast Cancer: A Systematic Review and Meta-Analysis of Cancer-Related Secondary Lymphedema</title>
<author><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L." last="Askew">Robert L. Askew</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S." last="Mungovan">Kristi S. Mungovan</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yan Xing" sort="Yan Xing" uniqKey="Yan Xing" last="Yan Xing">YAN XING</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center, Sinclair School of Nursing, University of Missouri</s1>
<s2>Columbia, Missouri</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0088040</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 11-0088040 INIST</idno>
<idno type="RBID">Pascal:11-0088040</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000200</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000758</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000246</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000246</idno>
<idno type="wicri:doubleKey">0008-543X:2010:Cormier J:lymphedema:beyond:breast</idno>
<idno type="wicri:Area/Main/Merge">005F40</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20665892</idno>
<idno type="wicri:Area/PubMed/Corpus">002974</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002974</idno>
<idno type="wicri:Area/PubMed/Curation">002974</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002974</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002974</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002974</idno>
<idno type="wicri:Area/Ncbi/Merge">003C82</idno>
<idno type="wicri:Area/Ncbi/Curation">003C82</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003C82</idno>
<idno type="wicri:doubleKey">0008-543X:2010:Cormier J:lymphedema:beyond:breast</idno>
<idno type="wicri:Area/Main/Merge">005833</idno>
<idno type="wicri:Area/Main/Curation">005E77</idno>
<idno type="wicri:Area/Main/Exploration">005E77</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Lymphedema Beyond Breast Cancer: A Systematic Review and Meta-Analysis of Cancer-Related Secondary Lymphedema</title>
<author><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L." last="Askew">Robert L. Askew</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S." last="Mungovan">Kristi S. Mungovan</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yan Xing" sort="Yan Xing" uniqKey="Yan Xing" last="Yan Xing">YAN XING</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
<affiliation wicri:level="2"><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center, Sinclair School of Nursing, University of Missouri</s1>
<s2>Columbia, Missouri</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Cancer</title>
<title level="j" type="abbreviated">Cancer</title>
<idno type="ISSN">0008-543X</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Cancer</title>
<title level="j" type="abbreviated">Cancer</title>
<idno type="ISSN">0008-543X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bibliographic review</term>
<term>Breast Neoplasms (complications)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Breast cancer</term>
<term>Cancerology</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Lymphedema</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Malignant tumor</term>
<term>Metaanalysis</term>
<term>Neoplasms (complications)</term>
<term>Postoperative Complications</term>
<term>Quality Control</term>
<term>Risk Factors</term>
<term>Second cancer</term>
<term>Surgery</term>
<term>Treatment</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Complications postopératoires</term>
<term>Contrôle de qualité</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Tumeurs ()</term>
<term>Tumeurs du sein ()</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Postoperative Complications</term>
<term>Quality Control</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Complications postopératoires</term>
<term>Contrôle de qualité</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Lymphoedème</term>
<term>Revue bibliographique</term>
<term>Métaanalyse</term>
<term>Cancer du sein</term>
<term>Cancérologie</term>
<term>Second cancer</term>
<term>Tumeur maligne</term>
<term>Chirurgie</term>
<term>Traitement</term>
<term>Tumeurs</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Chirurgie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND: Secondary lymphedema is a debilitating, chronic, progressive condition that commonly occurs after the treatment of breast cancer. The purpose of the current study was to perform a systematic review and meta-analysis of the oncology-related literature excluding breast cancer to derive estimates of lymphedema incidence and to identify potential risk factors among various malignancies. METHODS: The authors systematically reviewed 3 major medical indices (MEDLINE, Cochrane Library databases, and Scopus) to identify studies (1972-2008) that included a prospective assessment of lymphedema after cancer treatment. Studies were categorized according to malignancy, and data included treatment, complications, lymphedema measurement criteria, lymphedema incidence, and follow-up interval. A quality assessment of individual studies was performed using established criteria for systematic reviews. Bayesian meta-analytic techniques were applied to derive summary estimates when sufficient data were available. RESULTS: A total of 47 studies (7779 cancer survivors) met inclusion criteria: melanoma (n = 15), gynecologic malignancies (n = 22), genitourinary cancers (n = 8), head/neck cancers (n = 1), and sarcomas (n = 1). The overall incidence of lymphedema was 15.5% and varied by malignancy (P < .001): melanoma, 16% (upper extremity, 5%; lower extremity, 28%); gynecologic, 20%; genitourinary, 10%; head/neck, 4%; and sarcoma, 30%. Increased lymphedema risk was also noted for patients undergoing pelvic dissections (22%) and radiation therapy (31%). Objective measurement methods and longer follow-up were both associated with increased lymphedema incidence. CONCLUSIONS: Lymphedema is a common condition affecting cancer survivors with various malignancies. The incidence of lymphedema is related to the type and extent of treatment, anatomic location, heterogeneity of assessment methods, and length of follow-up.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Missouri (État)</li>
<li>Texas</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name>
</region>
<name sortKey="Armer, Jane M" sort="Armer, Jane M" uniqKey="Armer J" first="Jane M." last="Armer">Jane M. Armer</name>
<name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L." last="Askew">Robert L. Askew</name>
<name sortKey="Mungovan, Kristi S" sort="Mungovan, Kristi S" uniqKey="Mungovan K" first="Kristi S." last="Mungovan">Kristi S. Mungovan</name>
<name sortKey="Ross, Merrick I" sort="Ross, Merrick I" uniqKey="Ross M" first="Merrick I." last="Ross">Merrick I. Ross</name>
<name sortKey="Yan Xing" sort="Yan Xing" uniqKey="Yan Xing" last="Yan Xing">YAN XING</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005E77 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005E77 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:11-0088040
   |texte=   Lymphedema Beyond Breast Cancer: A Systematic Review and Meta-Analysis of Cancer-Related Secondary Lymphedema
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Lymphedema Beyond Breast Cancer: A Systematic Review and Meta-Analysis of Cancer-Related Secondary Lymphedema

Lymphedema Beyond Breast Cancer: A Systematic Review and Meta-Analysis of Cancer-Related Secondary Lymphedema

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.